Bond Primary Antibody Diluent - FDA Registration 47dea20bcf29deba0f7a0e00a40a619e
Access comprehensive regulatory information for Bond Primary Antibody Diluent in the Myanmar medical device market through Pure Global AI's free database. This medical device is registered under FDA ID 47dea20bcf29deba0f7a0e00a40a619e and manufactured by Leica Biosystems Newcastle Ltd. The device was registered on October 19, 2022.
This page provides complete registration details including manufacturer information, authorized representative details, and regulatory compliance data from the official Myanmar FDA medical device database. Pure Global AI offers free access to Myanmar's complete medical device registry.
Free Database
Powered by Pure Global AI
FDA Official Data
47dea20bcf29deba0f7a0e00a40a619e
Bond Primary Antibody Diluent
FDA ID: 47dea20bcf29deba0f7a0e00a40a619e
Device Classification
Brand Name
Leica
Registration Information
Analysis ID
47dea20bcf29deba0f7a0e00a40a619e
Registration Date
October 19, 2022
Manufacturer
Authorized Representative

